CClinicalTrials.gg
CompletedNCT02724111Updated Oct 13, 2017Results posted

Effect of Neuromuscular Blockade on Operating Conditions and Overall Satisfaction During Spinal Surgery

A Phase 4 interventional study of sufficient dose of rocuronium and sugammadex 10 min after position change in Neuromuscular Blockade, Surgery and Anesthesia, sponsored by Korea University Guro Hospital. Completed at 1 site in Korea, Republic of. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2017-10-13.

Sponsored by Korea University Guro Hospital · Phase 4, Interventional, and Supportive care

Phase
Phase 4
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

The investigators aim to investigate operating conditions, postoperative recovery and overall satisfaction of surgeons between deep neuromuscular blockade (NMB) group and restricted NMB group during spinal surgery under general anesthesia. The investigators hypothesize that this study can present good surgical conditions, postoperative recovery outcomes and overall satisfaction of surgeons in deep NMB group, thereby proving the advantages of deep NMB as well as flaws of restricted NMB in spine surgeries.

Read the detailed description
  • Group treatment (Arms): group treated with restricted neuromuscular blockade (NMB) (Group RB); group treated with deep NMB (Group DB) → randomized allocation (subjects: motor-evoked potential [MEP] not monitored surgeries)
  • Inclusion criteria: American Society of Anesthesiologists (ASA) physical status I-II adults, aged 18-75 years, scheduled for elective spinal surgery (cervical or lumbar surgeries which have lesions no more than 3 spinal levels and not monitored by MEP) of duration >1 hour and prone position under total intravenous anesthesia (TIVA).
  • Exclusion criteria: Pregnancy, the receipt of medication known to interfere with neuromuscular blockade, diseases affecting neuromuscular transmission, and the history of hypersensitivity on rocuronium or sugammadex. The patients who will have hemodynamic instability, mean blood pressure increase or fall of > 30% from baseline (lasting for more than 5min), and blood loss > 1 L during surgery, and MEP monitored surgeries.
  • Outcome Measures

    • Primary outcome: Mean value of peak inspiratory pressure recorded every 15 minutes.
    • Secondary outcomes:

      1. The number of body movements (including cough or any diaphragm movement).
      2. The degree of bleeding of each patient scaled by surgeons (Intraoperative scale for assessment of operating condition of surgical field: 0 - No bleeding, 1 - Slight bleeding - no suctioning of blood required, 2 - Slight bleeding - occasional suctioning required but not threatened the operative field, 3 - Slight-bleeding - frequent suctioning of blood was required that threatens the operative field a few seconds after suctioning, 4 - Moderate bleeding - frequent suctioning of blood was required which threatens the operative field directly after suctioning, 5 - Sever bleeding - continuous suctioning of blood was required which severely threatened the operative field make the surgery not possible).
      3. The muscle tone of each patient scaled by surgeons (1: muscle tone is good, suitable for surgery; 2: muscle tone is moderate, but do not affect the operation; 3: muscle tone is hard, making the operation difficult.).

        • Three time-points of assessment of the muscle tone: ① At the placement of back muscle retractor for opening the operating site after the skin and subcutaneous incision, ② At the screw insertion through the pedicle of spine during surgery, ③ At the other period (overall muscle tone).
      4. Mean value of pressure of back muscle retractor placed in the operating site (recorded every 15 minutes): measured by the pressure probe placed between the retractor and the back muscle.
      5. Overall satisfaction of surgeons for the surgical condition will be assessed by the surgeons who perform surgery using numerical rating scale (NRS; 1-10) after surgery.
      6. Recovery profiles including eye opening time, extubation time and sedation score (the Observer's Assessment of Alertness/ Sedation (OAA/S) score; awake, 5 to unresponsive, 1) every 10 min for 1 hour at postanesthesia care unit (PACU).
      7. Postoperative adverse events
02

Conditions studied

  • Neuromuscular Blockade
  • Surgery
  • Anesthesia
  • Spinal Diseases

Browse trials for

Keywords

  • Neuromuscular blockade
  • Surgical rating scale
  • Rocuronium
  • Sugammadex
  • Spinal surgery
  • General anesthesia
03

In context

Spinal Diseases

267 studies on the registry are indexed under Spinal Diseases; 54 are open to participants now.

This study's enrollment of 90 is above the median of 52 across 166 interventional studies indexed under Spinal Diseases.

Browse Spinal Diseases studies →

Lead sponsor

Korea University Guro Hospital is the lead sponsor of 83 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • American Society of Anesthesiologists (ASA) physical status I-II adult patients scheduled for elective spinal (cervical or lumbar) surgery under general anesthesia

Exclusion criteria

Exclusion Criteria:

  • Pregnancy
  • Present medication known to interfere with neuromuscular blockade
  • Diseases affecting neuromuscular transmission
  • History of hypersensitivity on rocuronium or sugammadex
  • Emergent spinal surgery
  • Spinal surgeries which have lesions more than 3 spinal levels
  • Spinal surgeries which have duration less than 1 hour
  • Spinal surgeries which are not performed under prone position
  • Spinal surgeries which are not performed under total intravenous anesthesia (TIVA).
  • Patients who will have hemodynamic instability (mean blood pressure increase or fall of > 30% from baseline lasting for more than 5 min) during surgery
  • Patients who will have blood loss > 1 L during surgery
  • MEP monitored spinal surgeries
05

Study design

Phase
Phase 4
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
90 participants (actual)

Study arms

  • Experimental
    deep neuromuscular blockade

    This arm will be given sufficient dose of rocuronium. In this Arm group, rocuronium will be administered to maintain deep neuromuscular blockade \[NMB\] (train-of-four \[TOF\] count 0, post-tetanic count \[PTC\] of 1-2 twitches) until the end of surgery and the reversal of NMB will be performed by sugammadex 4 mg/kg at the end of surgery'.

    Drug: sufficient dose of rocuronium

  • Active comparator
    restricted neuromuscular blockade

    This arm will not be given sufficient dose of rocuronium. In this Arm group, sugammadex will be administered according to the prescribing indications (4 mg/kg for deep neuromuscular blockade \[NMB\] state or 2 mg/kg for moderate NMB or less) to reverse the NMB 10 min after position change (sugammadex 10 min after position change \[a prone position\]). Thereafter, muscle relaxants will not be injected any more throughout the surgery except the following situations: If the patients show any body movement during surgery or if surgeons express any complaint about muscle tone (the muscle tone: grade 3), rescue rocuronium 5 mg will be administered and the number of body movements and rescue rocuronium administration (dose) will be recorded.

    Drug: sugammadex 10 min after position change

Interventions

  • Drugsufficient dose of rocuronium

    Also known as: sugammadex at the end of surgery

  • Drugsugammadex 10 min after position change

    Also known as: restricted dose of rocuronium

06

What researchers measure

Primary outcomes

  1. Mean Value of Peak Inspiratory Pressure

    This outcome is the mean value of the peak inspiratory pressure measured at each 15 minute during the anesthesia, which can reflect the degree of the tone of respiratory muscles. As muscle tone increases, airway pressure usually increases due to increased tone of abdominal muscle and respiratory muscles including diaphragm. The longer the surgery goes, the higher the airway pressure gets. Also, as neurospinal surgeries are operated in the prone position, the potential for increased airway pressure is high. As airway pressure gets higher, intrathoracic pressure and intraabdominal pressure also become higher. These consequences may bring about similar results with detrimental effects derived from marked increase in intraabdominal pressure in laparoscopic abdominal surgeries

    Time frame: Every 15 minutes during anesthesia, up to 3 hours

Secondary outcomes

  1. Mean Value of Pressure of Back Muscle Retractor

    Mean value of pressure of back muscle retractor placed in the operating site (recorded every 15 minutes during the placement of the retractor): measured by the pressure probe placed between the retractor and the back muscle.

    Time frame: Every 15 minutes at the period of the retractor placement during surgery, up to 2 hours

  2. Overall Satisfaction of Surgeons for the Surgical Condition

    Overall satisfaction of surgeons for the surgical condition will be assessed by the surgeons who perform surgery using numerical rating scale (NRS; 1-10) after surgery (1, worst; 10, best).

    Time frame: After surgery

  3. The Muscle Tone

    The muscle tone of each patient at the screw insertion through the pedicle of spine during surgery scaled by surgeons (1: muscle tone is good, suitable for surgery; 2: muscle tone is moderate, but do not affect the operation; 3: muscle tone is hard, making the operation difficult.).

    Time frame: at the screw insertion through the pedicle of spine during surgery

  4. The Number of Body Movements

    The number of body movements (including cough or any diaphragm movement) observed during the surgery.

    Time frame: At the occurrence of the event during surgery, up to 3 hours

  5. The Degree of Bleeding

    2.The degree of bleeding of each patient scaled by surgeons (Intraoperative scale for assessment of operating condition of surgical field: 0 - No bleeding, 1 - Slight bleeding - no suctioning of blood required, 2 - Slight bleeding - occasional suctioning required but not threatened the operative field, 3 - Slight-bleeding - frequent suctioning of blood was required that threatens the operative field a few seconds after suctioning, 4 - Moderate bleeding - frequent suctioning of blood was required which threatens the operative field directly after suctioning, 5 - Severe bleeding - continuous suctioning of blood was required which severely threatened the operative field make the surgery not possible).

    Time frame: Continuously observed during the whole period of surgery, up to 3 hours

  6. Recovery Time (Time to Reach Sedation Score 5 at Postanesthesia Care Unit (PACU).

    the time to reach sedation score 5 (the Observer's Assessment of Alertness/ Sedation (OAA/S) score; awake, 5 to unresponsive, 1) at PACU

    Time frame: every 10 min for 1 hour at PACU.

  7. Adverse Events : The Postoperative Nausea and Vomiting Occurrence in Subject

    The occurrence of any adverse events was recorded in the post-anesthesia care unit (PACU) and a ward during the postoperative 24 hours.

    Time frame: during the postoperative 24 hours

07

Results

Posted Oct 13, 2017

Participant flow

This study was a single-site study recruited and performed at Korea University Guro Hospital, a general hospital, Seoul, South Korea, from 15 May 2016 to 16 February 2017.

Participant flow — Overall Study
MilestoneDeep Neuromuscular BlockadeRestricted Neuromuscular Blockade
Started4545
Completed4340
Not completed25
Withdrew: Protocol violation25

Outcome measures

PrimaryMean Value of Peak Inspiratory Pressure

This outcome is the mean value of the peak inspiratory pressure measured at each 15 minute during the anesthesia, which can reflect the degree of the tone of respiratory muscles. As muscle tone increases, airway pressure usually increases due to increased tone of abdominal muscle and respiratory muscles including diaphragm. The longer the surgery goes, the higher the airway pressure gets. Also, as neurospinal surgeries are operated in the prone position, the potential for increased airway pressure is high. As airway pressure gets higher, intrathoracic pressure and intraabdominal pressure also become higher. These consequences may bring about similar results with detrimental effects derived from marked increase in intraabdominal pressure in laparoscopic abdominal surgeries

Time frame:
Every 15 minutes during anesthesia, up to 3 hours
Reported as:
Mean · cmH2O
Mean Value of Peak Inspiratory Pressure
cmH2ODeep Neuromuscular BlockadeRestricted Neuromuscular Blockade
Mean Value of Peak Inspiratory Pressure18.4 ± 1.120.2 ± 1.1
Statistical analysis
  • Deep Neuromuscular Blockade vs Restricted Neuromuscular Blockade · t-test, 2 sided · p = <0.001
SecondaryMean Value of Pressure of Back Muscle Retractor

Mean value of pressure of back muscle retractor placed in the operating site (recorded every 15 minutes during the placement of the retractor): measured by the pressure probe placed between the retractor and the back muscle.

Time frame:
Every 15 minutes at the period of the retractor placement during surgery, up to 2 hours
Reported as:
Mean · mmHg
Mean Value of Pressure of Back Muscle Retractor
mmHgDeep Neuromuscular BlockadeRestricted Neuromuscular Blockade
Mean Value of Pressure of Back Muscle Retractor81.2 ± 9.1100 ± 7.3
Statistical analysis
  • Deep Neuromuscular Blockade vs Restricted Neuromuscular Blockade · t-test, 2 sided · p = <0.001
SecondaryOverall Satisfaction of Surgeons for the Surgical Condition

Overall satisfaction of surgeons for the surgical condition will be assessed by the surgeons who perform surgery using numerical rating scale (NRS; 1-10) after surgery (1, worst; 10, best).

Time frame:
After surgery
Reported as:
Mean · Scores on a scale (NRS; 1-10)
Overall Satisfaction of Surgeons for the Surgical Condition
Scores on a scale (NRS; 1-10)Deep Neuromuscular BlockadeRestricted Neuromuscular Blockade
Overall Satisfaction of Surgeons for the Surgical Condition8 ± 1.33.1 ± 1.2
Statistical analysis
  • Deep Neuromuscular Blockade vs Restricted Neuromuscular Blockade · t-test, 2 sided · p = <0.001
SecondaryThe Muscle Tone

The muscle tone of each patient at the screw insertion through the pedicle of spine during surgery scaled by surgeons (1: muscle tone is good, suitable for surgery; 2: muscle tone is moderate, but do not affect the operation; 3: muscle tone is hard, making the operation difficult.).

Time frame:
at the screw insertion through the pedicle of spine during surgery
Reported as:
Mean · Scores on a scale (NRS; 1-3)
The Muscle Tone
Scores on a scale (NRS; 1-3)Deep Neuromuscular BlockadeRestricted Neuromuscular Blockade
The Muscle Tone1.3 ± 0.72.5 ± 0.7
Statistical analysis
  • Deep Neuromuscular Blockade vs Restricted Neuromuscular Blockade · Chi-squared · p = <0.001
SecondaryThe Number of Body Movements

The number of body movements (including cough or any diaphragm movement) observed during the surgery.

Time frame:
At the occurrence of the event during surgery, up to 3 hours
Reported as:
Mean · number of event
The Number of Body Movements
number of eventDeep Neuromuscular BlockadeRestricted Neuromuscular Blockade
The Number of Body Movements0 ± 02 ± 1
Statistical analysis
  • Deep Neuromuscular Blockade vs Restricted Neuromuscular Blockade · Chi-squared · p = <0.001
SecondaryThe Degree of Bleeding

2.The degree of bleeding of each patient scaled by surgeons (Intraoperative scale for assessment of operating condition of surgical field: 0 - No bleeding, 1 - Slight bleeding - no suctioning of blood required, 2 - Slight bleeding - occasional suctioning required but not threatened the operative field, 3 - Slight-bleeding - frequent suctioning of blood was required that threatens the operative field a few seconds after suctioning, 4 - Moderate bleeding - frequent suctioning of blood was required which threatens the operative field directly after suctioning, 5 - Severe bleeding - continuous suctioning of blood was required which severely threatened the operative field make the surgery not possible).

Time frame:
Continuously observed during the whole period of surgery, up to 3 hours
Reported as:
Mean · Scores on a scale (NRS; 0-5)
The Degree of Bleeding
Scores on a scale (NRS; 0-5)Deep Neuromuscular BlockadeRestricted Neuromuscular Blockade
The Degree of Bleeding1.8 ± 0.73.3 ± 0.7
Statistical analysis
  • Deep Neuromuscular Blockade vs Restricted Neuromuscular Blockade · t-test, 2 sided · p = <0.001
SecondaryRecovery Time (Time to Reach Sedation Score 5 at Postanesthesia Care Unit (PACU).

the time to reach sedation score 5 (the Observer's Assessment of Alertness/ Sedation (OAA/S) score; awake, 5 to unresponsive, 1) at PACU

Time frame:
every 10 min for 1 hour at PACU.
Reported as:
Mean · minute
Recovery Time (Time to Reach Sedation Score 5 at Postanesthesia Care Unit (PACU).
minuteDeep Neuromuscular BlockadeRestricted Neuromuscular Blockade
Recovery Time (Time to Reach Sedation Score 5 at Postanesthesia Care Unit (PACU).10.5 ± 7.917 ± 11.4
Statistical analysis
  • Deep Neuromuscular Blockade vs Restricted Neuromuscular Blockade · t-test, 2 sided · p = 0.06
SecondaryAdverse Events : The Postoperative Nausea and Vomiting Occurrence in Subject

The occurrence of any adverse events was recorded in the post-anesthesia care unit (PACU) and a ward during the postoperative 24 hours.

Time frame:
during the postoperative 24 hours
Reported as:
Count of participants · Participants
Adverse Events : The Postoperative Nausea and Vomiting Occurrence in Subject
ParticipantsDeep Neuromuscular BlockadeRestricted Neuromuscular Blockade
Adverse Events : The Postoperative Nausea and Vomiting Occurrence in Subject118
Statistical analysis
  • Deep Neuromuscular Blockade vs Restricted Neuromuscular Blockade · Chi-squared · p = 0.202

Adverse events

Collected over during the postoperative 24 hours. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Deep Neuromuscular Blockade0/43 (0%)0/43 (0%)11/43 (25.6%)
Restricted Neuromuscular Blockade0/40 (0%)0/40 (0%)8/40 (20%)
Most frequent other events
Most frequent other events
EventDeep Neuromuscular BlockadeRestricted Neuromuscular Blockade
nausea or vomitingGastrointestinal disorders11/438/40

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Deep Neuromuscular BlockadeRestricted Neuromuscular BlockadeTotal
<=18 years000
Between 18 and 65 years303161
>=65 years13922
Age, Continuous
Age, Continuous(years)Deep Neuromuscular BlockadeRestricted Neuromuscular BlockadeTotal
Median61 (37 to 75)60 (30 to 75)60 (30 to 75)
Sex: Female, Male
Sex: Female, Male(Participants)Deep Neuromuscular BlockadeRestricted Neuromuscular BlockadeTotal
Female312960
Male121123
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)Deep Neuromuscular BlockadeRestricted Neuromuscular BlockadeTotal
Korean434083
Region of Enrollment
Region of Enrollment(Participants)Deep Neuromuscular BlockadeRestricted Neuromuscular BlockadeTotal
South Korea434083
Height (m)
Height (m)(meter)Deep Neuromuscular BlockadeRestricted Neuromuscular BlockadeTotal
Mean1.59 ± 0.071.58 ± 0.081.59 ± 0.07
Weight (kg)
Weight (kg)(kg)Deep Neuromuscular BlockadeRestricted Neuromuscular BlockadeTotal
Mean59.8 ± 8.560 ± 6.959.9 ± 7.7
08

Study locations

1 site
  • Korea University Guro Hospital
    Seoul, 08308, Korea, Republic of
09

References and documents

Study documents

  • Study protocol · Feb 4, 2016
  • Statistical analysis plan · Feb 4, 2016
  • Informed consent form · Jun 9, 2016

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 13, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02724111
Lead sponsor
Korea University Guro Hospital
Collaborators
Merck Sharp & Dohme LLC
Responsible party
Byung Gun Lim (Associate Professor, Korea University Guro Hospital) — Principal investigator
First posted
Mar 31, 2016
Start date
May 15, 2016
Primary completion
Feb 16, 2017
Completion
Feb 16, 2017
Results posted
Oct 13, 2017
Last update
Oct 13, 2017

Study contacts

Byung Gun Lim, Ph.D.
principal investigator · Korea University Guro Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion